Severe refractory CIDP: a case series of 10 patients treated with bortezomib

Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects

(2016) Constance Manso et al.   BRAIN

Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility Loci

(2016) Chiara Campo et al.   NEUROCHEMICAL RESEARCH

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy

(2016) Jérôme J. Devaux et al.   NEUROLOGY

Rituximab in multiple sclerosis

(2016) Jonatan Salzer et al.   NEUROLOGY

Inhibition of the neuronal NFκB pathway attenuates bortezomib-induced neuropathy in a mouse model

(2016) Albert Alé et al.   NEUROTOXICOLOGY

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

(2016) Antonio Palumbo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bortezomib Treatment for Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis

(2016) Volker Behrendt et al.   JAMA Neurology

Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

(2015) Jan D. Lünemann et al.   Nature Reviews Neurology

Proteasome inhibitors as experimental therapeutics of autoimmune diseases

(2015) Sue Verbrugge et al.   ARTHRITIS RESEARCH & THERAPY

Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy

(2015) Jiri Minarik et al.   PLoS One

A Critical Role for ABCG1 in Macrophage Inflammation and Lung Homeostasis

(2014) A. J. Wojcik et al.   JOURNAL OF IMMUNOLOGY

Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg

(2014) L. Querol et al.   NEUROLOGY

Neurotoxicity induced by antineoplastic proteasome inhibitors

(2014) Albert Alé et al.   NEUROTOXICOLOGY

Plasma cells in immunopathology: concepts and therapeutic strategies

(2014) Benjamin Tiburzy et al.   Seminars in Immunopathology

Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success

(2012) Benjamin M Greenberg et al.   Multiple Sclerosis Journal

Myeloperoxidase-Specific Plasma Cell Depletion by Bortezomib Protects from Anti-Neutrophil Cytoplasmic Autoantibodies-Induced Glomerulonephritis

(2011) J. Bontscho et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature

(2010) L. Benedetti et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

European Federation of Neurological Societies/Peripheral Nerve Society Guideline* on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Socie

(2010)   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial

(2010) Ivo N van Schaik et al.   LANCET NEUROLOGY

Practical considerations on the use of rituximab in autoimmune neurological disorders

(2010) Mixalis L. Kosmidis et al.   Therapeutic Advances in Neurological Disorders

Circulating subsets and CD4+CD25+regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy

(2009) Lara Sanvito et al.   AUTOIMMUNITY

Proteasome inhibition suppresses Schwann cell dedifferentiationin vitroandin vivo

(2009) Hyun Kyoung Lee et al.   GLIA

Inhibition of the proteasome influences murine and human dendritic cell development in vitro and in vivo

(2009) Elisabeth Zinser et al.   IMMUNOBIOLOGY

Incidence and prevalence of CIDP and the association of diabetes mellitus

(2009) R. S. Laughlin et al.   NEUROLOGY

Proteasome inhibition suppresses essential immune functions of human CD4+T cells

(2008) Carsten Berges et al.   IMMUNOLOGY

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

(2008) Richard AC Hughes et al.   LANCET NEUROLOGY

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

(2008) Kirsten Neubert et al.   NATURE MEDICINE